PRINCETON - Princeton University officials have decided to give students a meningitis vaccine that hasn't been approved in the U.S. in order to stop the spread of the disease.
The decision came yesterday after school officials met to discuss their options. The manufacturer of the vaccine says that it will take at least a month to make enough doses for the Ivy League school.
Last week, the Food and Drug Administration approved importing the vaccine, Bexsero, for possible use on Princeton's campus. The vaccine is approved in Europe and Australia. It's the only vaccine for use against the type B meningococcal bacteria.
Last week, health officials confirmed the school's seventh case of meningitis since March. No one has died.
Meningitis can be spread through kissing, coughing or lengthy contact.
The school tells students to wash their hands, cover their mouths when coughing and not share items such as drinking glasses and utensils.